SEP 17, 2015 9:44 AM PDT

Enabling the Innate Immune System to Fight Cancer

WRITTEN BY: Kara Marker
Cancer immunotherapy efforts have been mainly concentrated on the adaptive immune system, some even connecting epigenetic therapy and immunotherapy to prevent cancer cells from blocking activation of T cells. Today, a promising new study in the journal Immunity shares promising results of experiments focused on the innate immune system and its role in the fight against cancer.

What if we could help the body fight cancer all on its own, instead of pumping the body full of chemicals?
Focusing on the adaptive immune system makes cancer treatments more difficult to develop due to the specificity of T cells, B cells, antibodies, and their targets. Each cancer type and patient cancer case could potentially need a unique treatment of immunotherapy if manipulating the adaptive immune system. Dr. Maya Saleh, leader of the study published in Immunity and professor at McGill University, describes the more general, possibly quicker action of enabling the immune system to detect and fight cancer: innate immune cells "broadly survey tissues for the presence of 'danger' signals." The key word here is "broadly." 

In the study, Saleh and her team looked at experimental and control mice with colorectal cancer to determine the impact of cancer growth and spread. Some mice had impaired immune systems, and results showed that mice with unimpaired immune systems had less cancer growth and spread. Saleh's team was also able to identify specific innate immune cells that were active in preventing cancer growth.

NLRP3, a gene that codes for the production of cryopyrin protein, regulates the innate immune response to injury and invasion and also engages other immune cells (U.S. National Library of Medicine). In their study with colorectal cancer mice, Saleh's team saw NLRP3 act as a sensor that activated an effector cytokine, Interleukin 18. According to the National Center for Biotechnology Information, IL-18 is a proinflammatory cytokine that instigates natural killer (NK) cells activity. Saleh's team found the same action in the mice study. NK cells are innate lymphocytes that recognize abnormal cells (Nature). Cancer cells definitely fit under the definition of "abnormal" - seeing as they grow uncontrollably and irregularly. 

Now that this team from McGill University has demonstrated the potential of the innate immune system to target cancer cells and inhibit their growth and spread in the body, the options for therapeutics are many. Harnessing this ability of the innate immune system will be a paramount next step in the fight against cancer.

Check out the following Nature video to hear and see a great overview of current cancer immunotherapies.


Sources: Medical Xpress and McGill University
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 15, 2020
Immunology
APR 15, 2020
Does COVID-19 Attack the Immune System like HIV?
Researchers from the US and China have found that COVID-19 can destroy T cells, a type of lymphocyte that plays a key ro ...
APR 20, 2020
Immunology
APR 20, 2020
Making Sense of the T Cell Response Spectrum
T cells go through a sort of “training” process throughout life, and scientists recently discovered that the ...
MAY 14, 2020
Immunology
MAY 14, 2020
Antibody-laden Nanoparticles to Help COVID Patients Breathe Easy
Antibodies are a powerful countermeasure against COVID-19. Not only can they relieve symptoms in patients experiencing s ...
MAY 18, 2020
Microbiology
MAY 18, 2020
An Antibody Against SARS May Neutralize SARS-CoV-2
SARS-CoV caused an outbreak of SARS in 2003. Samples collected from those patients back then may help us against SARS-Co ...
JUN 15, 2020
Drug Discovery & Development
JUN 15, 2020
FDA Approves HPV Vaccine to Prevent Throat Cancer
For around a decade, research has suggested that Gardasil, an HPV vaccine, could prevent throat cancer, a condition that ...
JUN 23, 2020
Immunology
JUN 23, 2020
Nanosponges Mop up Viruses to Treat COVID Infections
  Scientists have developed an experimental therapy for COVID-19 that uses coated nanoparticles to intercept SARS-C ...
Loading Comments...